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Accepted for publication Mar 2, 2016 Zika virus is a mosquito-borne virus in the Flavivirus genus that is closely related to dengue, West Nile, and yellow fever viruses. After its discovery in 1947, 1 Zika virus was known to cause sporadic cases of mild, self-limited illness in persons living in Africa and Asia. The first widespread outbreak of Zika virus infection was recognized on Yap Island, Federated States of Micronesia, in 2007 2 ; outbreaks in Southeast Asia and the western Pacific followed, including a large outbreak in French Polynesia in 2013-2014. 3 The virus in the French Polynesia outbreak has been phylogenetically linked to the virus that emerged in Brazil in May 2015, 4 when the first local transmission of Zika virus in the Americas was reported. 5 Zika virus quickly spread throughout the country, with an estimated 440 000 to 1 300 000 suspected cases by the end of 2015. 6 In October 2015, the Brazilian Ministry of Health reported increasing numbers of infants born with microcephaly. 7 From October 2015 through February 2016, >5000 infants with suspected microcephaly had been reported, with confirmation of microcephaly in about one-third of the first 1300 infants who underwent evaluation. 8 Guillain-Barré syndrome has also been described in conjunction with Zika virus infection. 9 Although there is increasing supportive evidence, a causal relationship has not yet been established between Zika virus infection and either microcephaly or Guillain-Barré syndrome.
Given the widespread nature of the Zika virus epidemic in the Americas, the temporally associated increase in microcephaly and GuillainBarré syndrome in Brazil, and the retrospective findings of a cluster of microcephaly and neurologic disorders associated with Zika virus in French Polynesia, the World Health Organization declared Zika virus a Public Health Emergency of International Concern on February 1, 2016. 10 Local transmission was reported in 31 countries and territories in the Americas as of February 29, 2016 , including some US territories. 11 Based on the distributions of its primary mosquito vector, Aedes aegypti, and another possible vector, Aedes albopictus, local Zika virus transmission is possible in the continental United States. 12 Because Zika virus transmission has been documented in many countries, pediatric health care providers in the United States are likely to become involved in the evaluation and management of infants and children with possible Zika virus infection as well as discussions regarding its prevention. To assist pediatric providers, the present article reviews information on Zika virus, its epidemiologic characteristics, clinical presentation in children, laboratory testing, treatment, and methods of prevention.
ZIKA VIRUS

Vectors
Humans and nonhuman primates are the likely principal vertebrate hosts for Zika virus, which is primarily transmitted to humans through the bite of mosquitoes, most commonly Aedes aegypti and possibly Aedes albopictus. 12 Within the continental United States, these Aedes species are primarily found in the South, Midwest, and the Great Plains, with small pockets in the Southwest and California (http:// www. cdc. gov/ chikungunya/ resources/ vector-control. html). Aedes species mosquitoes are aggressive daytime feeders. They live in and around human households, are difficult to eradicate, and are able to reproduce in small water containers. 13
Routes of Transmission
Although mosquito-borne transmission is the main route of exposure, Zika virus infection has also been reported to occur via laboratory exposure 14 and sexual transmission. 15 Maternal-fetal transmission during pregnancy has been well documented, [16] [17] [18] [19] [20] [21] [22] and intrapartum transmission has also been reported. 23 Other flaviviruses have been transmitted via breast milk, [24] [25] [26] but no cases of Zika virus infection associated with breastfeeding have been reported. Zika virus RNA can be present in breast milk. 23 However, based on current evidence, the potential risk of Zika virus transmission through breast milk is outweighed by the known benefits of breastfeeding. 27 Although Zika virus RNA has been found in saliva 28 and urine, 29 no evidence exists that Zika virus can be transmitted through these routes.
Zika Virus Infection
Most persons with Zika virus infection are asymptomatic. 2 Among those with symptoms, the illness is generally mild and self-limited. Features most often observed include maculopapular rash, fever, arthralgia, and nonpurulent conjunctivitis; symptoms typically last several days to 1 week. 30 The incubation period for Zika virus in humans is unknown but is believed to be similar to that of other flaviviruses, in the range of 3 to 14 days. 31 All age groups are at risk for Zika virus infection; in the Yap Island outbreak, the attack rate for symptomatic Zika virus disease among children (<19 years of age) was lower than that for adults. 2 
CLINICAL FEATURES
Fetal
Although maternal-fetal transmission of Zika virus during pregnancy has been documented, [18] [19] [20] [21] [22] the incidence of congenital Zika virus infection and the frequency of adverse outcomes among pregnancies infected with Zika virus are unknown. Although microcephaly is the adverse infant outcome for which there is the most evidence, information on the health effects associated with congenital Zika virus infection is limited. Since Zika virus emerged in Brazil, >5000 newborns with suspected microcephaly have been reported, although the number of cases is likely to be lower when a full investigation is completed. 8 Because no standard definition exists for microcephaly, monitoring its prevalence has been challenging; studies have used different cutoffs (>2 or 3 SDs below the mean for gestational age and gender or below the 3rd or 5th percentile). 32 The number of suspected cases with microcephaly reported to Brazil's Ministry of Health over recent months is markedly higher than the 150 to 200 cases per year previously reported. 33 Some have questioned whether this increase might be due to misdiagnosis related to different cutoffs or overreporting related to increased awareness of the possible association with Zika virus. 34 These questions have led investigators to call for standardized measurement of head circumference and use of appropriate growth standards to improve surveillance of microcephaly that might be associated with Zika virus. 32 Congenital Zika virus infection has been confirmed by using reverse transcription polymerase chain reaction (RT-PCR) testing (amniotic fluid, placenta, fetal serum, fetal brain tissue, and fetal cerebrospinal fluid) or immunohistochemistry (placenta, fetal brain tissue, and products of conception) in 7 fetuses or infants with microcephaly, 3 early pregnancy losses, and 1 elective pregnancy termination (Table 1) . [17] [18] [19] [20] [21] [22] Among these fetuses and infants, other congenital anomalies identified on fetal ultrasound and MRI included brain atrophy and asymmetry, hydranencephaly, ventriculomegaly, cerebral calcifications, abnormally formed or absent brain structures (eg, corpus callosum, thalami, pons, cerebellar vermis, brainstem), bilateral cataracts, intraocular calcifications, and hydrops fetalis. 17, [19] [20] [21] [22] In addition to microcephaly, postnatal examination findings included ophthalmologic (eg, microphthalmia, cataracts, optic nerve pallor, macular chorioretinitis) and neurologic (eg, arthrogryposis, hypertonia, dysphagia, seizures) abnormalities. 17, [20] [21] [22] The autopsy of 1 infant revealed agyria, hydrocephalus, and multifocal calcifications in the cortex and subcortex. 19 Pathologic analyses of some of the aforementioned infants and fetuses have provided insight into the pathogenesis of congenital Zika virus infection. 18, 19 In 1 study, Zika virus RNA and antigens were detected on pathologic analysis of brain tissues from 2 newborns with microcephaly and in placental tissues from 2 early miscarriages. 18 In the newborns, detection of Zika virus RNA by RT-PCR and histopathologic changes of infection were limited to the brain. In another autopsy performed after a pregnancy termination, Zika virus, as evidenced by RT-PCR, immunofluorescence, and electron microscopy, was present only in the brain; no other fetal organs were affected. 19 Placental calcifications and a low placental-fetal weight ratio were also seen. These findings have led investigators to suggest that Zika virus is neurotropic and might also cause placental damage.
Reports of infants with suspected congenital Zika virus infection provide additional information ( Table 2) . Clinical information on the first 35 infants to be enrolled in the Brazilian Ministry of Health microcephaly registry was recently reported. 35 Although none of these infants underwent Zika virus testing, congenital Zika virus infection was suspected on the basis of all mothers residing in areas with local transmission and three-quarters reporting a rash during the first or second trimester of pregnancy. In addition to microcephaly, postnatal neuroimaging results revealed calcifications, ventriculomegaly, and neuronal migration disorders, and the infants had abnormal neurologic findings (eg, hypertonia, hyperreflexia, irritability, seizures). Findings of microcephaly, cortical and subcortical atrophy, and redundant scalp skin in some infants are suggestive of fetal brain disruption sequence, in which disruption of fetal brain growth leads to skull collapse. 36 Other findings included talipes and arthrogryposis, likely to be secondary to neurologic involvement. Ophthalmologic abnormalities (including chorioretinal atrophy, optic nerve hypoplasia and pallor, and lens subluxation) have been described in infants born with microcephaly who are suspected of having congenital Zika virus infection. [37] [38] [39] Because information on infants with congenital Zika virus infection is limited, it is unclear whether other central nervous system manifestations beyond microcephaly might occur (eg, cognitive impairment in the absence of microcephaly or structural abnormalities). Furthermore, while Zika virus seems to exhibit neurotropism, 18, 19 involvement of other organ systems cannot be excluded.
Vertical transmission of other flaviviruses seems to occur rarely; this transmission has not been associated with an increased risk for congenital anomalies. Although 1 infant born to a mother with West Nile virus encephalitis at 27 weeks' gestation had cerebral destruction and chorioretinitis, 40 rates of birth defects in a West Nile virus pregnancy registry were not significantly increased compared with baseline, 41 and a follow-up study suggested no adverse effects of West Nile virus on development. 42 Prenatal dengue virus infection does not seem to increase the risk for congenital anomalies. 43 Maternal-fetal transmission of other non-flavivirus infections (eg, rubella virus, cytomegalovirus, lymphocytic choriomeningitis virus, Toxoplasma gondii) has been associated with microcephaly. 44 Other manifestations of these congenital infections include various brain abnormalities (eg, intracranial calcifications, hydrocephalus), eye abnormalities (eg, cataracts, glaucoma, chorioretinitis), and hearing impairment.
Although no information on longterm outcomes of infants with microcephaly related to Zika virus infection is available, head circumference at birth generally reflects intrauterine brain growth. Based on microcephaly due to other causes, infants with severe microcephaly associated with Zika virus infection are likely to be at risk for long-term adverse outcomes, including seizures, cognitive impairment, and hearing and vision impairments. 45 Congenital microcephaly can be associated with prenatal exposure to other infectious and noninfectious (eg, alcohol, mercury) agents and with genetic conditions; evaluation for other 
Neonatal
To date, we are aware of 2 reports of presumed perinatally acquired Zika virus infection. 23 One mother developed pruritic rash 2 days before delivery; her infant remained asymptomatic. The second mother developed fever, myalgia, and pruritic rash 3 days after delivery; her infant developed thrombocytopenia and a transient rash 4 days after birth.
Both mother-infant pairs tested positive for Zika virus RNA in serum postnatally and were discharged in good health. Both mothers were likely to have been viremic during labor, raising the possibility of intrapartum transmission. Postnatal transmission via breast milk or saliva was also possible, but transmission via these routes has not been reported in the literature.
Perinatal transmission of other flaviviruses has been associated with severe illness. Neonates who acquire dengue virus infection through presumed perinatal transmission have developed fever, thrombocytopenia, and hemorrhage. 43 A range of illness severity was seen among 3 infants with West Nile virus infection transmitted during the perinatal period (1 each with rash, West Nile virus encephalitis, and West Nile virus meningitis). 41 The spectrum of illness in neonates who acquire Zika virus perinatally is unknown.
Infant and Child
Although data are limited, most children infected with Zika virus through mosquito bites have been mildly affected or asymptomatic, similar to adults. During the Yap Island outbreak, among those with symptoms (age range, 1-76 years), fever, macular or papular rash, arthralgia, and conjunctivitis were most frequently observed. Six publications describe clinical features of Zika virus infection in 10 children ranging in age from 3 to 16 years ( Table 3) . [46] [47] [48] [49] [50] [51] Illness duration was <1 week, and common manifestations included fever, malaise, headache, and myalgia. Seven of 10 children described in case reports presented with gastrointestinal symptoms; whether these symptoms occur more frequently in children than in adults is unknown. Although not seen in the 7 children for whom information is available, rash has been prominent in Zika virus outbreaks. 2 laboratory-confirmed Zika virus infection in Brazil (age range, 2-57 years) 6 ; additional details were not provided. Whether these neurologic conditions are caused by Zika virus infection is currently unknown.
Diagnosis
The Centers for Disease Control and Prevention (CDC) has released updated interim guidelines for health care providers caring for infants and children with possible Zika virus infection. 27 
LABORATORY TESTING Molecular Diagnostics
Given its high sensitivity and specificity for detecting Zika virus, 56 RT 60 Aspirin and other salicylates should be avoided in children due to an association with Reye's syndrome, and nonsteroidal antiinflammatory drugs should be used cautiously in children with dehydration and avoided in infants aged <6 months due to inadequate information on pharmacokinetics and potential for nephrotoxicity. 61 Nonsteroidal antiinflammatory drugs can also increase the risk of hemorrhagic complications in patients with dengue virus infection and thus should be avoided until dengue infection has been excluded. 62 To reduce the risk of transmission to others, infected patients should take precautions to prevent mosquito bites, especially during the first week of illness when they are likely to be viremic. 
PREVENTION
RESOURCES
Information on Zika virus and its consequences is rapidly accruing. Readers may find the following resources helpful to stay abreast of developments:
• 
